Stonebridge Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Stonebridge Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.01M	Buy	+16,715	New	+$974K	0.46%	42
2025 Q2	$894K	Sell	19,315 -600	-3%	-$29.5K	0.35%	44
2025 Q1	$1.22M	Sell	19,915 -2,000	-9%	-$117K	0.53%	38
2024 Q4	$1.24M	Sell	21,915 -175	-0.8%	-$9.78K	0.51%	39
2024 Q3	$1.14M	Sell	22,090 -500	-2%	-$23.5K	0.45%	41
2024 Q2	$938K	Hold	22,590	–	–	0.4%	41
2024 Q1	$1.23M	Buy	22,590 +25	+0.1%	+$1.27K	0.55%	40
2023 Q4	$1.16M	Hold	22,565	–	–	0.56%	41
2023 Q3	$1.31M	Sell	22,565 -6,040	-21%	-$370K	0.72%	36
2023 Q2	$1.83M	Sell	28,605 -700	-2%	-$46.9K	0.85%	33
2023 Q1	$2.03M	Sell	29,305 -250	-0.8%	-$17.6K	0.98%	29
2022 Q4	$2.13M	Sell	29,555 -2,050	-6%	-$155K	1.02%	28
2022 Q3	$2.25M	Sell	31,605 -2,625	-8%	-$190K	1.16%	28
2022 Q2	$2.64M	Sell	34,230 -150	-0.4%	-$11.4K	1.2%	26
2022 Q1	$2.51M	Buy	34,380 +1,000	+3%	+$67.1K	0.91%	33
2021 Q4	$2.08M	Sell	33,380 -1,250	-4%	-$73.3K	0.72%	37
2021 Q3	$2.05M	Sell	34,630 -400	-1%	-$26.3K	0.75%	36
2021 Q2	$2.34M	Buy	35,030 +500	+1%	+$32.6K	0.85%	35
2021 Q1	$2.18M	Sell	34,530 -1,450	-4%	-$90.2K	0.83%	35
2020 Q4	$2.23M	Buy	35,980 +250	+0.7%	+$15.4K	0.92%	32
2020 Q3	$2.15M	Buy	35,730 +2,255	+7%	+$136K	0.99%	32
2020 Q2	$1.99M	Buy	33,475 +170	+0.5%	+$10.2K	1.02%	31
2020 Q1	$1.86M	Sell	33,305 -2,250	-6%	-$138K	1.04%	30
2019 Q4	$2.28M	Buy	35,555 +1,848	+5%	+$106K	1%	32
2019 Q3	$1.71M	Sell	33,707 -9,103	-21%	-$428K	0.79%	34
2019 Q2	$1.94M	Buy	42,810 +23,728	+124%	+$1.11M	0.77%	35
2019 Q1	$910K	Buy	19,082 +13,190	+224%	+$657K	0.33%	59
2018 Q4	$306K	Hold	5,892	–	–	0.12%	99
2018 Q3	$366K	Hold	5,892	–	–	0.13%	96
2018 Q2	$330K	Sell	5,892 -3,000	-34%	-$162K	0.12%	100
2018 Q1	$521K	Hold	8,892	–	–	0.19%	79
2017 Q4	$558K	Sell	8,892 -2,500	-22%	-$156K	0.2%	78
2017 Q3	$726K	Sell	11,392 -100	-0.9%	-$5.84K	0.27%	67
2017 Q2	$640K	Buy	11,492 +100	+0.9%	+$5.44K	0.24%	71
2017 Q1	$620K	Hold	11,392	–	–	0.25%	70
2016 Q4	$666K	Hold	11,392	–	–	0.28%	64
2016 Q3	$615K	Hold	11,392	–	–	0.26%	65
2016 Q2	$838K	Hold	11,392	–	–	0.38%	52
2016 Q1	$727K	Sell	11,392 -1,500	-12%	-$94.6K	0.31%	57
2015 Q4	$887K	Hold	12,892	–	–	0.38%	53
2015 Q3	$763K	Hold	12,892	–	–	0.34%	57
2015 Q2	$858K	Hold	12,892	–	–	0.35%	58
2015 Q1	$831K	Sell	12,892 -300	-2%	-$18.8K	0.34%	60
2014 Q4	$779K	Hold	13,192	–	–	0.3%	65
2014 Q3	$675K	Hold	13,192	–	–	0.26%	77
2014 Q2	$640K	Buy	13,192 +1,300	+11%	+$64.1K	0.24%	86
2014 Q1	$617K	Sell	11,892 -6,990	-37%	-$372K	0.26%	83
2013 Q4	$1M	Buy	18,882 +85	+0.5%	+$4.33K	0.4%	49
2013 Q3	$870K	Hold	18,797	–	–	0.39%	56
2013 Q2	$840K	Buy	+18,797	New	+$816K	0.39%	55

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stonebridge Capital Management's BMY Position: Q1 2026 in Review

Stonebridge Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 16,715 shares worth $1.01M. The stake represents 0.46% of the portfolio and ranks #42 among its holdings. This is a return to the name: Stonebridge Capital Management previously reported a position in BMY as recently as Q2 2025.

Stonebridge Capital Management first reported a position in BMY in Q2 2013 and has held it in 50 quarters since. The position peaked at $2.64M in Q2 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Stonebridge Capital Management held 16,715 shares of Bristol-Myers Squibb worth $1.01M as of Q1 2026.
Bristol-Myers Squibb was a new Stonebridge Capital Management position in Q1 2026.
Bristol-Myers Squibb made up 0.46% of Stonebridge Capital Management's portfolio in Q1 2026, its #42 holding.
Stonebridge Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 50 quarters since.
Stonebridge Capital Management's Bristol-Myers Squibb position peaked at $2.64M in Q2 2022.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Stonebridge Capital Management's 13F filing for Q1 2026, filed 14 Apr 2026.